Effects of resistance exercise on treatment outcome and laboratory parameters of Takayasu arteritis with magnetic resonance imaging diagnosis: A randomized parallel controlled clinical trial.

Guoce Li, Fenghai Liu, Yan Wang, Meng Zhao, Yancheng Song, Lei Zhang
Author Information
  1. Guoce Li: Department of MRI, Cangzhou Central Hospital, Cangzhou, China. ORCID
  2. Fenghai Liu: Department of MRI, Cangzhou Central Hospital, Cangzhou, China.
  3. Yan Wang: Department of Neurology, Cangzhou Central Hospital, Cangzhou, China.
  4. Meng Zhao: Department of MRI, Cangzhou Central Hospital, Cangzhou, China.
  5. Yancheng Song: Department of MRI, Cangzhou Central Hospital, Cangzhou, China.
  6. Lei Zhang: Department of MRI, Cangzhou Central Hospital, Cangzhou, China.

Abstract

BACKGROUND: Elevated tumor necrosis factor-α (TNF-α) is correlated with refractory Takayasu arteritis (TA), and resistance exercise have been shown to inhibit TNF-α.
HYPOTHESIS: We aimed to explore the effect of resistance exercise in the clinical management of TA.
METHODS: This clinical trial enrolled a total of 342 acute TA patients, who were subsequently randomized to undergo either resistance exercise or relaxation control twice per week for 12 weeks. The disease activity was defined using the primary outcome of Birmingham Vascular Activity Score (BVAS). Secondary outcomes included levels of plasma TNF-α and C-reactive protein (CRP), and the erythrocyte sedimentation rate (ESR).
RESULTS: BVAS scores along with other laboratory parameters obtained from the patients in the resistance exercise group showed a gradual decline throughout the course of the trial. By contrast, outcomes appeared largely unaltered in the relaxation control group patients. Analyses also revealed that plasma TNF-α displayed strong linear correlations with ESR, BVAS scores, and plasma CRP levels.
CONCLUSION: Resistance exercise could substantially improve treatment outcomes as well as laboratory parameters in patients with acute TA, probably through decreasing TNF-α.

Keywords

References

  1. QJM. 1994 Nov;87(11):671-8 [PMID: 7820541]
  2. Proc Nutr Soc. 2001 Aug;60(3):349-56 [PMID: 11681809]
  3. Ann Rheum Dis. 2008 Nov;67(11):1567-9 [PMID: 18677012]
  4. Eur J Clin Invest. 2017 Aug;47(8):600-611 [PMID: 28722106]
  5. Eur Heart J Case Rep. 2018 Dec 21;2(4):yty123 [PMID: 31020199]
  6. Wei Sheng Yan Jiu. 2015 Jul;44(4):610-4 [PMID: 26454959]
  7. Rheum Dis Clin North Am. 2007 Nov;33(4):777-86, vi [PMID: 18037116]
  8. Circ J. 2013;77(2):477-83 [PMID: 23100088]
  9. Arthritis Rheum. 2007 Mar;56(3):1000-9 [PMID: 17328078]
  10. Autoimmun Rev. 2012 Jul;11(9):678-84 [PMID: 22155781]
  11. Afr Health Sci. 2018 Mar;18(1):120-131 [PMID: 29977265]
  12. J Appl Physiol (1985). 2005 Apr;98(4):1154-62 [PMID: 15772055]
  13. Nutrients. 2019 Feb 07;11(2): [PMID: 30736479]
  14. Arthritis Rheum. 2004 Jul;50(7):2296-304 [PMID: 15248230]
  15. Intern Med. 2006;45(5):313-6 [PMID: 16596001]
  16. Arq Bras Cardiol. 2019 May;112(5):545-552 [PMID: 31038529]
  17. Brain Behav Immun. 2019 Jan;75:181-191 [PMID: 30394312]
  18. Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):111-26 [PMID: 26658771]
  19. Presse Med. 2015 Jun;44(6 Pt 2):e259-65 [PMID: 26033561]
  20. Biol Psychol. 2018 Mar;133:79-84 [PMID: 29408464]
  21. Clin Exp Rheumatol. 2012 Nov-Dec;30(6):922-8 [PMID: 23044074]
  22. Rev Bras Reumatol. 2010 May-Jun;50(3):291-8 [PMID: 21125165]
  23. Rheumatol Int. 2011 Jan;31(1):93-5 [PMID: 19851773]
  24. Pathol Microbiol (Basel). 1975;43(2-O):140-6 [PMID: 6933]
  25. Malays J Med Sci. 2013 May;20(3):44-50 [PMID: 23966824]
  26. Rheumatology (Oxford). 2006 May;45(5):545-8 [PMID: 16352633]
  27. Semin Arthritis Rheum. 2005 Apr;34(5 Suppl1):34-8 [PMID: 15852254]
  28. Science. 1993 Jan 1;259(5091):87-91 [PMID: 7678183]
  29. Immunol Cell Biol. 2016 Feb;94(2):146-50 [PMID: 26568029]
  30. Arthritis Care Res (Hoboken). 2017 Jun;69(6):892-902 [PMID: 27564917]
  31. Ann Rheum Dis. 2018 Mar;77(3):348-354 [PMID: 29191819]
  32. Semin Arthritis Rheum. 2017 Feb;46(4):529-535 [PMID: 27515155]
  33. BBA Clin. 2015 Apr 18;3:280-8 [PMID: 26673349]
  34. Ann Vasc Surg. 2013 Jul;27(5):671.e11-4 [PMID: 23809931]
  35. J Hepatol. 2017 Jan;66(1):142-152 [PMID: 27639843]
  36. Int Angiol. 2005 Sep;24(3):304-7 [PMID: 16158044]
  37. Life Sci. 2018 Jun 15;203:150-160 [PMID: 29698651]
  38. Arthritis Rheum. 1990 Aug;33(8):1129-34 [PMID: 1975175]
  39. Eur Rev Med Pharmacol Sci. 2009 Jan-Feb;13(1):63-5 [PMID: 19364087]
  40. Clin Cardiol. 2020 Nov;43(11):1273-1278 [PMID: 32761844]
  41. Clin Immunol. 2006 Feb-Mar;118(2-3):154-8 [PMID: 16337833]
  42. Dis Nerv Syst. 1977 Sep;38(9):703-8 [PMID: 332473]
  43. Arthritis Care Res (Hoboken). 2012 Jul;64(7):1079-83 [PMID: 22328491]

Grants

  1. 172302020/2017 Cangzhou Science and Technology Research and Development Guidance Plan Project

MeSH Term

Adult
Biomarkers
C-Reactive Protein
Disease Progression
Female
Humans
Magnetic Resonance Imaging
Male
Resistance Training
Takayasu Arteritis
Treatment Outcome
Tumor Necrosis Factor-alpha

Chemicals

Biomarkers
Tumor Necrosis Factor-alpha
C-Reactive Protein

Word Cloud

Created with Highcharts 10.0.0exerciseresistanceTNF-αTApatientsTakayasuarteritisclinicaltrialBVASoutcomesplasmalaboratoryparametersacuterandomizedrelaxationcontrolactivityoutcomeBirminghamlevelsC-reactiveproteinCRPESRscoresgrouptreatmentBACKGROUND:Elevatedtumornecrosisfactor-αcorrelatedrefractoryshowninhibitHYPOTHESIS:aimedexploreeffectmanagementMETHODS:enrolledtotal342subsequentlyundergoeithertwiceperweek12 weeksdiseasedefinedusingprimaryVascularActivityScoreSecondaryincludederythrocytesedimentationrateRESULTS:alongobtainedshowedgradualdeclinethroughoutcoursecontrastappearedlargelyunalteredAnalysesalsorevealeddisplayedstronglinearcorrelationsCONCLUSION:ResistancesubstantiallyimprovewellprobablydecreasingEffectsmagneticresonanceimagingdiagnosis:parallelcontrolledvascularscoreMRI

Similar Articles

Cited By